Rythera Therapeutics
Deerfield Beach, US · Founded 2020 · Delaware corporation
Find your way into Rythera Therapeutics
Sign up to see every warm intro you have to Rythera Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Rythera Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RB
Rhonda BhagwandeenNamed on SEC filing
DB
Dan BrowneNamed on SEC filing
SH
Stephen HoffmanNamed on SEC filing
RH
Reginald HardyNamed on SEC filing
MG
Marc GraboyesNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2022
▶$1.3MraisedMar 2022 · 7 investors · BiotechnologyRule 506(b)
▶$1.3MraisedMar 2022 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Rhonda BhagwandeenExecutive Officer
- Dan BrowneExecutive Officer, Director
- Stephen HoffmanDirector
- Reginald HardyExecutive Officer, Director
- Marc GraboyesExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.3M
- Minimum investment
- $25K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Rythera Therapeutics raised?
- Rythera Therapeutics has disclosed $1.3M raised across 1 round.
- Where is Rythera Therapeutics headquartered?
- Rythera Therapeutics is headquartered in Deerfield Beach, US.